Stimulant use still going strong. Revisiting... Misuse of amphetamines and related drugs

Advances in Psychiatric Treatment

Volumn 11, Issue 4, 2005, Pages 262-269

  Seivewright, Nicholas ^a   McMahon, Charles ^b   Egleston, Paul ^c  

^a SHEFFIELD HEALTH AND SOCIAL CARE NHS FOUNDATION TRUST   (United Kingdom)

^b Hawkhead Rd   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMANTADINE; AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; COCAINE; DESIPRAMINE; DEXAMPHETAMINE; DISULFIRAM; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; ILLICIT DRUG; LYSERGIDE; METHADONE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COCAINE DEPENDENCE; DRUG MISUSE; DRUG SCREENING; HALLUCINATION; HUMAN; MENTAL DISEASE; MOOD DISORDER; PARANOID PSYCHOSIS; PATIENT COUNSELING; UNITED KINGDOM;

EID: 21744455272     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.11.4.262     Document Type: Article

References (30)

1. Bowden-Jones, O., Iqbal, M. Z., Tyrer, P., et al (2004) Prevalence of personality disorder in alcohol and drug services and associated comorbidity. Addiction, 99, 1306-1314.
2. Carroll, K. M., Fenton, L. R., Ball, S. A., et al (2004) Efficacy of disulfiram and cognitive behavior therapy in cocaine dependent outpatients: a randomized placebo-controlled trial. Archives of General Psychiatry, 61, 264-272.
3. Cowen, P. J. (2005) New drugs, old problems. Advances in Psychiatric Treatment, 11, 19-27.
4. Crits-Cristoph, P., Siqueland, L., Blaine, J., et al (1999) Psychosocial treatments for cocaine dependence. Archives of General Psychiatry, 36, 493-502.
5. Curran, C., Byrappa, N. & McBride, A. (2004) Stimulant psychosis: systematic review. British Journal of Psychiatry, 185, 196-204.
6. de Lima, M. S., de Oliveira Soares, B. G., Reisser, A. A. P. & Farrell, M. (2002) Pharmacological treatment of cocaine dependence: a systematic review. Addiction, 97, 931-949.
7. Department of Health (2002) Mental Health Policy Implementation Guide: Dual Diagnosis Good Practice Guide. London: Stationery Office.
8. Drake, R. E. & Mueser, K. T. (2000) Psychosocial approaches to dual diagnosis. Schizophrenia Bulletin, 26, 105-118.
9. Edwards, J. G. (2005) Newer v. older antidepressants in long-term pharmacotherapy. Revisiting... Prevention of relapse and recurrence of depression. Advances in Psychiatric Treatment, 11, 184-194.
10. Gournay, K. (2005) The changing face of psychiatric nursing. Advances in Psychiatric Treatment, 11, 6-11.
11. Gowing, L. R., Henry-Edwards, S. M. & Irvine, R. G. (2002) The health effects of ecstasy. Drug and Alcohol Review, 21, 53-63.
12. Gossop, M., Marsden, J., Stewart, D., et al (2002) Changes in use of crack after drug misuse treatment: 4-5 year follow-up results from the National Treatment Outcome Research Study (NTORS). Drug and Alcohol Dependence, 66, 21-28.
13. Grabowski, J., Shearer, J., Merrill, J., et al (2004) Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addictive Behaviours, 29, 1439-1464.
14. Handy, C., Pates, R. & Barrowcliff, A. (1998) Drug use in South Wales: who uses Ecstasy anyway? Journal of Substance Misuse, 3, 82-88.
15. Higgins, S. T., Sigmon, S. C., Wong, C. J., et al (2003) Community reinforcement therapy for cocaine-dependent outpatients. Archives of General Psychiatry, 60, 1043-1052.
16. Mortimer, A. (2005) Another triumph of hope over experience? Advances in Psychiatric Treatment, 11, 277-285.
17. Penk, W. E., Flannery, R. B. Jr, Irvin, E., et al (2000) Characteristics of substance-abusing persons with schizophrenia: the paradox of the dually diagnosed. Journal of Addictive Diseases, 19, 23-30.
18. Plant, M. & Miller, P. (2000) Drug use has declined amongst teenagers in United Kingdom. BMJ, 320, 1536-1537.
19. Poole, R. & Brabbins, C. (1996) Drug induced psychosis. British Journal of Psychiatry, 168, 135-138.
20. Rawson, A. R., Marinelli-Casey, P., Anglin, M. D., et al (2004) A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction, 99, 708-717.
21. Rohsenow, D. J., Monti, P. M., Martin, R. A., et al (2004) Motivational enhancement and coping skills training for cocaine abusers: effects on substance use outcomes. Addiction, 99, 862-874.
22. Schaefer, M., Heinz, A. & Backmund, M. (2004) Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Addiction, 99, 1167-1175.
23. Seivewright, N. (2000) Community Treatment of Drug Misuse: More Than Methadone. Cambridge: Cambridge University Press.
24. Seivewright, N. & McMahon, C. (1996) Misuse of amphetamines and related drugs. Advances in Psychiatric Treatment, 2, 211-218.
25. Seivewright, N., Donmall, M., Douglas, J., et al (2000) Cocaine misuse treatment in England. International Journal of Drug Policy, 11, 203-215.
26. Seivewright, N., Iqbal, M. Z. & Bourne, H. (2004) Treating patients with comorbidities. In Drug Treatment: What Works? (eds P. Bean & T. Nemitz), pp. 123-141. London: Routledge.
27. Soar, K., Turner, J. J. D. & Parrott, A. C, (2001) Psychiatric disorders in Ecstasy (MDMA) users. A literature review focusing on personal predisposition and drug history. Human Psychopharmacology, 16, 641-645.
28. Swofford, C. D., Scheller-Gilkey, G., Miller, A. H., et al (2000) Double jeopardy: schizophrenia and substance use. American Journal of Drug and Alcohol Abuse, 26, 343-353.
29. Topp, L., Barker, B. & Degenhardt, L. (2004) The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug and Alcohol Dependence, 73, 33-40.
30. Weaver, T., Madden, P., Charles, V., et al (2003) Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry, 183, 304-313.